Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,360 INR | -0.45% | +6.24% | +0.34% |
May. 06 | Caplin Point Laboratories Gets Colombian Drug Regulator's Approval for Soft Gel Capsules Unit in India | MT |
Apr. 16 | Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.34% | 1.24B | |
+21.90% | 44.15B | |
+23.24% | 23.02B | |
+19.25% | 15.33B | |
+12.79% | 13.74B | |
+49.80% | 12.16B | |
-10.33% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.88% | 5.66B |
- Stock Market
- Equities
- CAPLIPOINT Stock
- News Caplin Point Laboratories Limited
- Caplin Point Gets Four Observations from US FDA After Inspection of Injectable Unit at Gummidipoondi, India